Uniphar (LON:UPR) Shares Down 3% - Here's Why

Uniphar plc (LON:UPR - Get Free Report) was down 3% during trading on Monday . The stock traded as low as GBX 320 ($4.30) and last traded at GBX 320 ($4.30). Approximately 3,014 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 47,909 shares. The stock had previously closed at GBX 329.75 ($4.43).

Wall Street Analysts Forecast Growth

Separately, Shore Capital reissued a "buy" rating on shares of Uniphar in a research report on Thursday, May 29th.

Uniphar Trading Up 1.0%

The company has a market capitalization of £980.54 million, a price-to-earnings ratio of 21.90 and a beta of 0.75. The company has a debt-to-equity ratio of 119.48, a quick ratio of 0.60 and a current ratio of 0.90. The firm has a fifty day moving average price of GBX 308.45 and a 200-day moving average price of GBX 245.34.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.